Amyloid beta-protein1-42 increases cAMP and apolipoprotein E levels which are inhibited by β1 and β2-adrenergic receptor antagonists in mouse primary astrocytes

Neuroscience

Volumn 142, Issue 3, 2006, Pages 655-660

  Igbavboa, U ^a   Johnson Anuna, L N ^a   Rossello, X ^a   Butterick, T A ^a   Sun, G Y ^b   Wood, W G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b University of Missouri   (United States)

Author keywords

Alzheimer's disease; amyloid beta protein; apolipoprotein E; astrocytes; beta adrenergic receptors; cAMP

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; DRUG INTERACTION; ENZYME IMMUNOASSAY; GENE EXPRESSION; METABOLISM; METHODOLOGY; NEWBORN; TIME; WESTERN BLOTTING;

ADRENERGIC BETA-ANTAGONISTS; AMYLOID BETA-PROTEIN; ANIMALS; ANIMALS, NEWBORN; APOLIPOPROTEINS E; ASTROCYTES; BLOTTING, WESTERN; CELLS, CULTURED; CYCLIC AMP; DRUG INTERACTIONS; GENE EXPRESSION; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; TIME FACTORS;

EID: 33749439315     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.06.056     Document Type: Article

References (38)

1. Aleong R., Aumont N., Dea D., and Poirier J. Non-steroidal anti-inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E protein. Eur J Pharmacol 18 (2003) 1428-1438
2. Baker J.G., Hall I.P., and Hill S.J. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: Differences between second messenger and receptor gene responses. Mol Pharmacol 64 (2003) 679-688
3. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., and Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76 (1985) 1501-1513
4. Cedazo-Mínguez A., Hamker U., Meske V., Veh R.W., Hellweg R., Jacobi C., Albert F., Cowburn R.F., and Ohm T.G. Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte cultures. Neuroscience 105 (2001) 651-661
5. Champagne D., Pearson D., Dea D., Rochford J., and Poirier J. The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: Implications for Alzheimer's disease. Neuroscience 121 (2003) 99-110
6. García M.A., Vázquez J., Giménez C., Valdivieso F., and Zafra F. Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. J Neurosci 16 (1996) 7550-7556
7. Göritz C., Mauch D.H., Nägler K., and Pfrieger F.W. Role of glia-derived cholesterol in synaptogenesis: New revelations in the synapse-glia affair. J Physiol 96 (2002) 257-263
8. Heneka M.T., Galea E., Gavriluyk V., Dumitrescu-Ozimek L., Daeschner J., O'Banion M.K., Weinberg G., Klockgether T., and Feinstein D.L. Noradrenergic depletion potentiates b-amyloid-induced cortical inflammation: Implications for Alzheimer's disease. J Neurosci 22 (2002) 2434-2442
9. Hirsch-Reinshagen V., Zhou S., Burgess B.L., Bernier L., McIsaac S.A., Chan J.Y., Tansley G.H., Cohn J.S., Hayden M.R., and Wellington C.L. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem 279 (2004) 41197-41207
10. Holtzman D.M., Fagan A.M., Mackey B., Tenkova T., Sartorius L., Paul S.M., Bales K., Ashe K.H., Irizarry M.C., and Hyman B.T. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol 47 (2000) 739-747
11. Hu J., LaDu M.J., and Van Eldik L.J. Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation. J Neurochem 71 (1998) 1626-1634
12. Huang H.-M., and Gibson G. Altered b-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer's donors. J Biol Chem 268 (1993) 14616-14621
13. 1-42. J Biol Chem 278 (2003) 17150-17157
14. Ignatius M.J., Gebicke-Harter P.J., Skene J.H., Schilling J.W., Weisgraber K.H., Mahley R.W., and Shooter E.M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A 83 (1986) 1125-1129
15. Jumker V., Becker A., Hühne R., Zembatov M., Ravati A., Culmsee C., and Krieglstein J. Stimulation of b-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol 446 (2002) 25-36
16. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., and Van Eldik L.J. Apolipoprotein E receptors mediate the effects of b-amyloid on astrocyte cultures. J Biol Chem 275 (2000) 33974-33980
17. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., and Van Eldik L.J. Apolipoprotein E and apolipoprotein E receptors modulate Ab-induced glial neuroinflammatory responses. Neurochem Int 39 (2001) 427-434
18. 2-and b3-adrenergic receptors increases brain tryptophan. J Pharmacol Exp Ther 305 (2003) 653-659
19. Liang Y., Lin S., Beyer T.P., Zhang Y., Wu X., Bales K.R., DeMattos R.B., May P.C., Li S.D., Jiang X.-C., Eacho P.I., Cao G., and Paul S.M. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J Neurochem 88 (2004) 623-634
20. Mahley R.W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
21. Martinez M., Hernandez A.I., and Heranz A. Increased cAMP immunostaining in cerebral vessels in Alzheimer's disease. Brain Res 922 (2001) 148-152
22. Mason R.P., Jacob R.F., Walter M.F., Mason P.E., Avdulov N.A., Chochina S.V., Igbavboa U., and Wood W.G. Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes. J Biol Chem 274 (1999) 18801-18807
23. Mauch D.H., Nägler K., Schumacher S., Göritz C., Müller E.-C., Otto A., and Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001) 1354-1357
24. Moulder K.L., Narita M., Chang L.K., Bu G., and Johnson Jr. E.M. Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide. J Neurochem 72 (1999) 1069-1080
25. Nathan B.P., Nisar R., Randall S., Short J., Sherrow M., Wong G.K., and Struble R.G. Apolipoprotein E is upregulated in olfactory bulb glia following peripheral receptor lesion in mice. Exp Neurol 172 (2001) 128-136
26. Pitas R.E., Boyles J.K., Lee S.H., Foss D., and Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917 (1987) 148-161
27. Poirier J., Hess M., May P.C., and Finch C.E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res 11 (1991) 97-106
28. Prapong T., Uemura E., and Hsu W.H. G protein and cAMP-dependent protein kinase mediate amyloid b-peptide inhibition of neuronal glucose uptake. Exp Neurol 167 (2001) 59-64
29. Rymer D.L., and Good T.A. The role of G protein activation in the toxicity of amyloidogenic Ab-(1-40), Ab-(25-35), and bovine calcitonin. J Biol Chem 276 (2001) 2523-2530
30. Soomets U., Mahlapuu R., Tehranian R., Jarvet J., Karelson E., Zilmer M., Iverfeldt K., Zorko M., Graslund A., and Langel U. Regulation of GTPase and adenylate cyclase activity by amyloid beta-peptide and its fragments in rat brain tissue. Brain Res 850 (1999) 179-188
31. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E: High-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90 (1993) 1977-1981
32. Wahrle S.E., Jiang H., Parsadanian M., Legleiter J., Han X., Fryer J.D., Kowalewski T., and Holtzman D.M. ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279 (2004) 40987-40993
33. Wang S.S., Kazantzi V., and Good T.A. A kinetic analysis of the mechanism of b-amyloid induced G protein activation. J Theor Biol 221 (2003) 269-278
34. Watson P.A. Accumulation of cAMP and calcium in S49 mouse lymphoma cells following hyposmotic swelling. J Biol Chem 264 (1989) 14735-14740
35. Weisgraber K.H., and Mahley R.W. Human apolipoprotein E: The Alzheimer's disease connection. FASEB J 10 (1996) 1485-1494
36. Xu J., Chailiminiuk M., Shu Y., Simonyi A., Sun A.Y., Weisman G., Wood W.G., and Sun G.Y. Prostaglandin E2 production in astrocytes: Regulation by nucleotide receptor agonists, oxidative and inflammatory agents. Prostaglandins Leukot Essent Fatty Acids 69 (2003) 437-448
37. Xu Q., Li Y.H., Cyras C., Sanan D.A., and Cordell B. Isolation and characterization of apolipoproteins from murine microglia. J Biol Chem 275 (2000) 31770-31777
38. Yamauchi K., Tozuka M., Hidaka E., Ueno I., Matsuda K., and Katsuyama K. Internalization of β-amyloid causes downregulaton of apolipoprotein E mRNA expression in neuroblastoma cells. Ann Clin Lab Sci 33 (2003) 68-78